Learn how to buy shares of Santen Pharmaceutical (4536.T) – Tutorial explained

santen pharmaceutical

Santen Pharmaceutical Co., Ltd. researches and develops, manufactures and markets pharmaceuticals and medical devices in Japan and internationally. It offers various pharmaceutical products to treat glaucoma and ocular hypertension, such as DE-111, which is in a phase III clinical trial; DE-117 in Japan; DE-126 which is in a phase 2b clinical trial; DE-128 in Europe, as well as in a phase 2/3 clinical trial in the United States; and DE-130A which is in a phase III clinical trial. In addition, the company provides DE-114A to treat allergic conjunctivitis; DE-076C for the treatment of vernal keratoconjunctivitis; and DE-109, which is in a phase 3 clinical trial to treat uveitis. In addition, it offers DE-127 to treat myopia, that it is in a phase 2/3 clinical trial in Japan, as well as phase 3 in Asia; and MD-16 for the treatment of cataracts. Additionally, the company offers over-the-counter pharmaceutical products. The company was previously known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.

Chart and share price of the company Santen Pharmaceutical (Tokyo)

5 d





2 and




Santen Pharmaceutical Co., Ltd.


Drug Manufacturers General



81 6 7664 8621

Basic information

Learn how to buy shares of Santen Pharmaceutical (4536.T) – Tutorial explained

Do you want to learn how to buy Santen Pharmaceutical (4536.T) shares in Tokyo safely and through a regulated and recognized broker? Do you like the fact of being able to invest your savings per month and make a profit on the stock market? Here I am going to show you how you can register a degiro account , a reliable Dutch investment broker and low commissions, and how you can get your first shares of Santen Pharmaceutical Co., Ltd. (4536.T) (4536 .T) quickly and intuitively.

What we will do is intuitive :

  • First of all, we are going to register on Degiro, a broker platform where we will pay for shares of Santen Pharmaceutical Co., Ltd. (4536.T) (4536.T).
  • Next we will add funds to execute our 1st investment in Degiro.
  • Once we have the funds, we will search for Santen Pharmaceutical with its Ticker, which is 4536.T.
  • Finally we will have to adjust the number of shares we want to buy, the price and the type of order.

It is possible that the step by step has been essential for you, so I am going to summarize the process with images.

How to register with the DeGiro broker

First we are going to register in DEGIRO from this link :

buy shares of Santen Pharmaceutical Co., Ltd. (4536.T)

It will ask us for an email, a name and a password to enter, and then we must continue with the link that they have sent us by email address.

Soon DEGIRO will ask us for the necessary information in order to accept our identification card . We must have our passport, ID or driving document, our mobile or cell phone and the account number that we are going to use to make our first deposit in IBAN format. If you do not perceive what method this format is, you can review this simple step by step that we did from Educaceps.es .

stock Santen Pharmaceutical

Once our account is verified, we can enter money from the Enter / Withdraw tab. We can make a transaction that will take two or three days, or we can make the deposit quickly using Sofort, a truly secure and 100% reliable payment gateway.

deposit money Santen Pharmaceutical

How to buy Santen Pharmaceutical (4536.T) shares through DEGIRO

When we have the money we have the possibility to buy our first share. You can use the place order button in the top right corner or use the DEGIRO search engine and type in the ticker. In the following screenshot you will see that I have put the Amazon Ticker but you have to put (4536.T), the Santen Pharmaceutical ticker. As we are talking about an action, we will check that the related results are listed and there we will see to find Santen Pharmaceutical. The most essential thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Santen Pharmaceutical Co., Ltd. (4536.T) is listed in Tokyo. This step is very fundamental so make no mistake.

american bag bradesco Santen Pharmaceutical

At the time of placing the order we have to be attentive to what I am going to explain to you . We can place a limit or market order. Imagine that you want to get a share of Santen Pharmaceutical, but its price is currently quite high. With this limit order we will enter the value at which we wish to make the purchase and until there are no shares for sale at a certain value, the purchase of the share will not be carried out. With a market order Degiro will buy the number of shares that we have indicated at the current sale price, which will be very close to today’s trading price.

limited company agenda Santen Pharmaceutical Co., Ltd. (4536.T)

In both cases it is essential that you look at the type of alignment: permanent or day . To serve as an example, in Spain, the stock market price is in the morning and until 1:00 p.m., and in the US it corresponds to the afternoon schedule in Spain. If an order is fixed, it will last until the point where it can be executed, but if you opt for the “of the day” option, at the end of the day, if it had not been executed, it will be deleted from your file in Activity – Pending orders.

I hope that this detailed text will help you to buy shares in Santen Pharmaceutical. Greetings.

  Company information
  • Address of Santen Pharmaceutical Co., Ltd. (4536.T): Grand Front Osaka Tower A 4-20 Ofuka-cho Kita-ku Osaka 530-8552 Japan 81 6 6321 7000 – Website: http://www.santen. com
  • Ticker: 4536.T
  • Industry: Unknown
  • Industry: Drug manufacturers
  • Number of employees: The number of workers is unknown
  • Listed market: Tokyo

key executives

Name Title Salary exercised Year of birth
Mr. Shigeo Taniuchi Pres, CEO and Representative Director N/A N/A 1973
Mr. Kazuo Koshiji Senior Corporate Director of Corp. Admin., CFO and Head of Fin. Admin. Division N/A N/A N/A
Mr. Minori Hara Corp. officer, Chief Information officer and Head of Digital Information Technology Division N/A N/A N/A
Ms. Kaori Itagaki Gen. Mang. of the Investor Relations Group N/A N/A N/A
Ms. Mika Masunari Corp. officer, Gen. Counsel, Chief Compliance officer and Head of Legal Compliance Division N/A N/A N/A
Akiko Yoshikawa Gen. Mang. of Corp. Communications Group N/A N/A N/A
Mr. Satoshi Suzuki Senior Corp. Officer and Director of Corp. Devel. Division N/A N/A N/A
Mr. Shinichi Teramachi Corp. official, Head of Sales Department Japan Sales and Marketing Division N/A N/A N/A
Mr. Ippei Kurihara Corp. official, Head of Marketing Department Japan Sales and Marketing Division N/A N/A N/A
Mr. Tomo Yashiki Corporate Officer and Head of the Human Resources Division N/A N/A N/A

Recent events of :

We have no recent events for this company.